Close Menu

WSJ’s MarketWatch interviews the CEO of Clinical Data, Drew Fromkin. They talk about his ideas on biomarkers, GINA, personalized medicine, and what it means for consumers whose confidence in genetic testing, and the insurance coverage they may or may not get, is just starting to improve.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Two researchers are calling for education for scientists on defending facts.

Researchers were among those who marched in London this weekend to call for another vote on Brexit.

Duke has agreed to pay $112.5 million to settle a lawsuit regarding its handling of data falsified by biologist Erin Potts-Kant. 

In PLOS this week: genetic factors influencing inorganic arsenic metabolism and toxicity, a germline variant in the cell adhesion molecule-coding gene DSCAM, and more.